USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 79,294 shares of the company’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $57.61, for a total transaction of $4,568,127.34. Following the transaction, the insider now owns 12,272,013 shares of the company’s stock, valued at $706,990,668.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Tuesday, September 5th, Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $58.41, for a total transaction of $2,336,400.00.
  • On Wednesday, August 2nd, Global Ltd Gull sold 14,533 shares of USANA Health Sciences stock. The stock was sold at an average price of $56.71, for a total transaction of $824,166.43.
  • On Tuesday, August 1st, Global Ltd Gull sold 25,467 shares of USANA Health Sciences stock. The stock was sold at an average price of $56.52, for a total transaction of $1,439,394.84.

Shares of USANA Health Sciences, Inc. (NYSE:USNA) traded up 0.35% on Thursday, hitting $57.35. 107,875 shares of the stock traded hands. The stock has a 50-day moving average price of $57.59 and a 200 day moving average price of $60.18. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00. The firm has a market cap of $1.40 billion, a P/E ratio of 14.90 and a beta of 1.10.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.06 by ($0.08). USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The company had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. During the same period in the prior year, the firm posted $2.07 earnings per share. The business’s revenue was down .5% on a year-over-year basis. Equities research analysts predict that USANA Health Sciences, Inc. will post $3.79 EPS for the current fiscal year.

USANA Health Sciences announced that its board has authorized a stock repurchase program on Tuesday, July 25th that allows the company to repurchase $64.60 million in shares. This repurchase authorization allows the company to repurchase up to 46% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “USANA Health Sciences, Inc. (USNA) Major Shareholder Sells $4,568,127.34 in Stock” was reported by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/09/14/usana-health-sciences-inc-usna-major-shareholder-sells-4568127-34-in-stock.html.

Several brokerages have recently issued reports on USNA. BidaskClub upgraded shares of USANA Health Sciences from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. Pivotal Research lowered their price target on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a report on Wednesday, July 26th.

A number of institutional investors have recently bought and sold shares of the business. USA Financial Portformulas Corp bought a new stake in USANA Health Sciences in the second quarter worth $691,000. Phocas Financial Corp. lifted its stake in USANA Health Sciences by 4.7% in the second quarter. Phocas Financial Corp. now owns 125,090 shares of the company’s stock worth $8,018,000 after purchasing an additional 5,575 shares during the last quarter. California State Teachers Retirement System lifted its stake in USANA Health Sciences by 0.5% in the second quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock worth $1,319,000 after purchasing an additional 100 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in USANA Health Sciences by 7.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,137 shares of the company’s stock worth $586,000 after purchasing an additional 616 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its stake in USANA Health Sciences by 711.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock worth $5,859,000 after purchasing an additional 80,145 shares during the last quarter. 44.90% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.